Background New technologies constitute an important cost-driver in healthcare, but the dynamics that lead to their emergence remains poorly understood from a health policy standpoint. The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.   Methods Our 5-year qualitative research program examined the proces...

background pharmacovigilance (pv) data are crucial for ensuring safety and effectiveness of medicines after drugs have been granted marketing approval. this paper describes the pv systems of india, uganda and south africa based on literature and key informant (ki) interviews and compares them with the world health organization’s (who’s) minimum pv requirements for a functional national pv syste...

background the unregulated availability and irrational use of tuberculosis (tb) medicines is a major issue of public health concern globally. governments of many low- and middle-income countries (lmics) have committed to regulating the quality and availability of tb medicines, but with variable success. regulation of tb medicines remains an intractable challenge in many settings, but the reason...

In this issue... The federal government designs the CRTC's regulatory policies to promote the entry of new firms into the market for wireline local access services using current facilities and technology. Yet the current pace of technological change means that competition cannot be measured simply by counting the number of competitors in the market. What is needed are incentives for firms to in...

Background Health apps are a booming, yet under-regulated market, with potential consumer harms in privacy and health safety. Regulation of the health app market tends to be siloed, with no single sector holding comprehensive oversight. We sought to explore this phenomenon by critically analysing how the problem of health app regulation is being presented and addressed in the policy arena...